Posted inBusiness Insights
Kedaara Capital Leads Bid for Controlling Stake in Olive PharmaScience
Private equity firm Kedaara Capital has emerged as the frontrunner to acquire a significant stake in Olive PharmaScience, a strategic move that industry analysts value at approximately ₹4,500 crore. The…
